CN106729436A - Detoxicating stagnation resolvation tonifying liver soup - Google Patents
Detoxicating stagnation resolvation tonifying liver soup Download PDFInfo
- Publication number
- CN106729436A CN106729436A CN201710049691.8A CN201710049691A CN106729436A CN 106729436 A CN106729436 A CN 106729436A CN 201710049691 A CN201710049691 A CN 201710049691A CN 106729436 A CN106729436 A CN 106729436A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- detoxicating
- rhizome
- mutual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 31
- 235000014347 soups Nutrition 0.000 title claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 29
- 239000000463 material Substances 0.000 claims abstract description 12
- 244000157790 Buglossoides arvense Species 0.000 claims abstract description 10
- 235000004256 Buglossoides arvense Nutrition 0.000 claims abstract description 10
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 10
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 10
- 241001660870 Cyrtomium Species 0.000 claims abstract description 10
- 241000096284 Gynochthodes officinalis Species 0.000 claims abstract description 10
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 10
- 241000405414 Rehmannia Species 0.000 claims abstract description 10
- 241000304432 Sedum sarmentosum Species 0.000 claims abstract description 10
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 10
- 240000008488 Thlaspi arvense Species 0.000 claims abstract description 10
- 235000008214 Thlaspi arvense Nutrition 0.000 claims abstract description 10
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 10
- 235000013976 turmeric Nutrition 0.000 claims abstract description 10
- 241000605422 Asparagus asparagoides Species 0.000 claims abstract description 9
- 244000241872 Lycium chinense Species 0.000 claims abstract description 9
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 9
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 9
- 229940079593 drug Drugs 0.000 claims abstract description 8
- 244000153955 Reynoutria sachalinensis Species 0.000 claims abstract description 6
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims abstract description 6
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 8
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 4
- 240000001341 Reynoutria japonica Species 0.000 claims description 4
- 230000033228 biological regulation Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims description 4
- 238000004062 sedimentation Methods 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 19
- 208000002672 hepatitis B Diseases 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 11
- 208000000419 Chronic Hepatitis B Diseases 0.000 abstract description 6
- 206010014080 Ecchymosis Diseases 0.000 abstract description 5
- 230000005764 inhibitory process Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000002787 reinforcement Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 17
- 208000002193 Pain Diseases 0.000 description 16
- 206010007247 Carbuncle Diseases 0.000 description 10
- 208000006454 hepatitis Diseases 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 229930182478 glucoside Natural products 0.000 description 7
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 206010017553 Furuncle Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 206010042674 Swelling Diseases 0.000 description 6
- 241000245665 Taraxacum Species 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- -1 glucoside methyl esters Chemical class 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 231100000283 hepatitis Toxicity 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 206010003011 Appendicitis Diseases 0.000 description 4
- 206010008909 Chronic Hepatitis Diseases 0.000 description 4
- YTZSBJLNMIQROD-SFBCHFHNSA-N Morroniside Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)O[C@@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YTZSBJLNMIQROD-SFBCHFHNSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 3
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010010741 Conjunctivitis Diseases 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 208000012287 Prolapse Diseases 0.000 description 3
- PZZRDJXEMZMZFD-ODPGBAFUSA-N Reynoutrin Natural products O[C@H]1[C@H](O)[C@@H](O)CO[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O PZZRDJXEMZMZFD-ODPGBAFUSA-N 0.000 description 3
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 210000000436 anus Anatomy 0.000 description 3
- BDCDNTVZSILEOY-UXYNSRGZSA-N avicularin Chemical compound O[C@@H]1[C@@H](O)[C@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O BDCDNTVZSILEOY-UXYNSRGZSA-N 0.000 description 3
- QIARVOTYSDZZQL-UHFFFAOYSA-N avicularin Natural products OCC1OC(Oc2cc(O)c3C(=O)C(=C(Oc3c2)c4ccc(O)c(O)c4)O)C(O)C1O QIARVOTYSDZZQL-UHFFFAOYSA-N 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 208000003512 furunculosis Diseases 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- ALRFYJWUVHBXLV-UHFFFAOYSA-N guaijaverin Natural products OC1COC(COC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O ALRFYJWUVHBXLV-UHFFFAOYSA-N 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- BDCDNTVZSILEOY-UHFFFAOYSA-N polystachoside Natural products OC1C(O)C(CO)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O BDCDNTVZSILEOY-UHFFFAOYSA-N 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 3
- 229940032091 stigmasterol Drugs 0.000 description 3
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 3
- 235000016831 stigmasterol Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000002105 tongue Anatomy 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 2
- YTZSBJLNMIQROD-UHFFFAOYSA-N (4aS)-1c-beta-D-glucopyranosyloxy-6xi-hydroxy-8t-methyl-(4ar,8ac)-5,6,8,8a-tetrahydro-1H,4aH-pyrano[3,4-c]pyran-4-carboxylic acid methyl ester Natural products C12C(C)OC(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O YTZSBJLNMIQROD-UHFFFAOYSA-N 0.000 description 2
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- HAIWUXASLYEWLM-UHFFFAOYSA-N D-manno-Heptulose Natural products OCC1OC(O)(CO)C(O)C(O)C1O HAIWUXASLYEWLM-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- HSNZZMHEPUFJNZ-UHFFFAOYSA-N L-galacto-2-Heptulose Natural products OCC(O)C(O)C(O)C(O)C(=O)CO HSNZZMHEPUFJNZ-UHFFFAOYSA-N 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- HAIWUXASLYEWLM-AZEWMMITSA-N Sedoheptulose Natural products OC[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@](O)(CO)O1 HAIWUXASLYEWLM-AZEWMMITSA-N 0.000 description 2
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 description 2
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- PLSSBWGEYMENGJ-UHFFFAOYSA-N Villoside Natural products CC1CCC2C1C(=O)OCC2COC1OC(CO)C(O)C(O)C1O PLSSBWGEYMENGJ-UHFFFAOYSA-N 0.000 description 2
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 2
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 2
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- COUXBBBIXWWAEP-AGUBZPQCSA-N asperuloside Natural products CC(=O)OCC1=C[C@@H]2OC(=O)C3=CO[C@@H](OC[C@H]4O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]4O)[C@H]1[C@H]23 COUXBBBIXWWAEP-AGUBZPQCSA-N 0.000 description 2
- IBIPGYWNOBGEMH-DILZHRMZSA-N asperuloside Chemical compound O([C@@H]1OC=C2C(=O)O[C@H]3C=C([C@@H]1[C@H]32)COC(=O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBIPGYWNOBGEMH-DILZHRMZSA-N 0.000 description 2
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 2
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 2
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940109262 curcumin Drugs 0.000 description 2
- 235000012754 curcumin Nutrition 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 150000007875 phellandrene derivatives Chemical class 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 229930006696 sabinene Natural products 0.000 description 2
- HSNZZMHEPUFJNZ-SHUUEZRQSA-N sedoheptulose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO HSNZZMHEPUFJNZ-SHUUEZRQSA-N 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 2
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 2
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- 150000000193 1,8-cineol derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- WCRMDMYSQWZTSF-UHFFFAOYSA-N 2-hydroxy-1-methoxy-3-methylanthracene-9,10-dione Chemical class O=C1C2=CC=CC=C2C(=O)C2=C1C=C(C)C(O)=C2OC WCRMDMYSQWZTSF-UHFFFAOYSA-N 0.000 description 1
- YJILUWQPXMLLTN-UHFFFAOYSA-N 2-methoxy-3-methylanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=C(OC)C(C)=C2 YJILUWQPXMLLTN-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- DLHXRDUXNVEIEY-UHFFFAOYSA-N 7-Methylcoumarin Chemical class C1=CC(=O)OC2=CC(C)=CC=C21 DLHXRDUXNVEIEY-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- DGDWCRWJRNMRKX-DILZHRMZSA-N Asperulosidic acid Chemical compound O([C@H]1[C@H]2[C@@H](C(=CO1)C(O)=O)[C@@H](O)C=C2COC(=O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGDWCRWJRNMRKX-DILZHRMZSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- GFJNBLOMWYSKSS-UHFFFAOYSA-N Isoglycyrol Natural products COc1c2CCC(C)(C)Oc2cc3OC(=O)c4c(oc5c(O)cccc45)c13 GFJNBLOMWYSKSS-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- MVAUGMLUJKTORM-UHFFFAOYSA-N Licoricidin Natural products COc1cc2OCC(Cc2cc1CC=C(C)C)c3ccc(O)c(CC=C(C)C)c3O MVAUGMLUJKTORM-UHFFFAOYSA-N 0.000 description 1
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- TYHJMEIBGDDCPA-UHFFFAOYSA-N N-Methylpelletierine Chemical compound CN1CCCCC1CC(C)=O TYHJMEIBGDDCPA-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- XQWFHGOIUZFQPJ-USTPAGJBSA-N Neoisoliquiritigenin Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)cc(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc1 XQWFHGOIUZFQPJ-USTPAGJBSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-LXGDFETPSA-N Neoisoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-LXGDFETPSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-UHFFFAOYSA-N Neoisoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1O)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-UHFFFAOYSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 241000362909 Smilax <beetle> Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041519 Spider naevus Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- CFWLRXJPRRCJTI-UHFFFAOYSA-N iso-glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CCC(C)(C)O2)C2=C1 CFWLRXJPRRCJTI-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- GBRZTUJCDFSIHM-KRWDZBQOSA-N licoricidin Chemical compound C1([C@@H]2COC=3C=C(O)C(CC=C(C)C)=C(C=3C2)OC)=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-KRWDZBQOSA-N 0.000 description 1
- GBRZTUJCDFSIHM-UHFFFAOYSA-N licorisoflavan B Natural products C1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OCC1C1=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-UHFFFAOYSA-N 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000004169 miliaria rubra Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 150000003901 oxalic acid esters Chemical class 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses one kind detoxicating stagnation resolvation tonifying liver soup, the raw medicinal material of use is respectively:20 parts of giant knotweed, 20 parts of Sculellaria barbata, 25 parts of smilax, 15 parts of the radix paeoniae rubrathe, 15 parts of turmeric, 20 parts of field pennycress, 20 parts of dandelion, 10 parts of radix bupleuri, 25 parts of oldenlandia diffusa, 25 parts of stringy stonecrop, 15 parts of the fruit of Chinese wolfberry, 18 parts of radix pseudostellariae, 15 parts of rhizome of cyrtomium, 15 parts of Asian puccoon, 6 parts of Radix Glycyrrhizae, 15 parts of Morinda officinalis, 20 parts of prepared rhizome of rehmannia, 15 parts of rattletop, 20 parts of Ramulus Taxilli.Complementation is imitated with the raw medicinal material property of medicine selected by top, has evaded the mutual inhibition, mutual restraint between two drugs, the choosing of the mutual-detoxication of compatibility between medicine, made medicine mutual reinforcement between, mutually make effect significantly, with enhance immunity effect.Qinghua ecchymosis, the nourishing liver and kidney, purpose that replenishes qi to invigorate the spleen can be reached in treatment.It is for oral administration that there is definite curative effect to chronic hepatitis B.
Description
Technical field
The present invention relates to a kind of field of Chinese medicines, and in particular to one kind detoxicating stagnation resolvation tonifying liver soup, with Qinghua ecchymosis, nourishing liver
Kidney, the effect for replenishing qi to invigorate the spleen are obvious for chronic hepatitis B effect.
Background technology
Chronic hepatitis B(Abbreviation hepatitis B)Refer to hepatitis B test positive, the course of disease exceedes half a year or date of the onset not
Clearly and clinic has chronic hepatitis shower.Clinical manifestation is the symptoms such as weak, sitophobia, nausea, abdominal distension, hepatalgia.Hepatomegaly,
Quality is medium hardness, there is light tenderness.State of an illness severe one can with chronic liver disease face, spider angioma, liver palms, splenomegaly, liver function
Exception or persistent anomaly.According to clinical manifestation be divided into slightly, moderate and severe.And it refers to hepatitis B detection that chronic hepatitis B is carried
It is the positive, without chronic hepatitis symptom.The cause of disease:1. family spreads through sex intercourse;2. infantile period infection is viral;3. prevention consciousness is lacked;4.
Fail to pinpoint a disease in diagnosis;5. immunologic hypofunction person infection is viral.6. the past have other hepatitis histories infect virus person.
The content of the invention
It is an object of the invention to provide one kind detoxicating stagnation resolvation tonifying liver soup, with Qinghua ecchymosis, it is nourishing liver and kidney, replenish qi to invigorate the spleen
Effect, it is obvious for chronic hepatitis B effect.
The technical solution adopted by the present invention is:
The detoxicating stagnation resolvation tonifying liver soup, the raw medicinal material of use is respectively:It is 20 parts of giant knotweed, 20 parts of Sculellaria barbata, 25 parts of smilax, red
15 parts of Chinese herbaceous peony, 15 parts of turmeric, 20 parts of field pennycress, 20 parts of dandelion, 10 parts of radix bupleuri, 25 parts of oldenlandia diffusa, 25 parts of stringy stonecrop, matrimony vine
15 parts of son, 18 parts of radix pseudostellariae, 15 parts of rhizome of cyrtomium, 15 parts of Asian puccoon, 6 parts of Radix Glycyrrhizae, 15 parts of Morinda officinalis, 20 parts of prepared rhizome of rehmannia, 15 parts of rattletop, mulberry
It is parasitic 20 parts.
It is following steps that its preparation method is:Step one), weigh 20 parts of bulk drug polygonum cuspidatum, 20 parts of Sculellaria barbata, smilax
25 parts, 15 parts of the radix paeoniae rubrathe, 15 parts of turmeric, 20 parts of field pennycress, 20 parts of dandelion, 10 parts of radix bupleuri, 25 parts of oldenlandia diffusa, stringy stonecrop 25
Part, 15 parts of the fruit of Chinese wolfberry, 18 parts of radix pseudostellariae, 15 parts of rhizome of cyrtomium, 15 parts of Asian puccoon, 6 parts of Radix Glycyrrhizae, 15 parts of Morinda officinalis, 20 parts of prepared rhizome of rehmannia, rattletop
15 parts, 20 parts of Ramulus Taxilli, go the removal of impurity, are eluriated rapidly with cold boiled water water, drain aqueous, dry;
Step 2), step one)Obtained raw medicinal material is respectively prepared medicine materical crude slice, puts in suitable decocting device, adds clear water appropriate, leaching
Bubble suitable time, is heated to boiling, keeps slight boiling condition certain hour(About 1.5 ~ 2 hours), separate fried liquid;
Step 3), step 2)The dregs of a decoction after being filtered add water appropriate decoction, after decocting 2 ~ 3 times by regulation, merge
Fried liquid, filtering or the fried liquid of sedimentation separation;
Step 4), step 3)Obtained Chinese medicine preparation is packed, and obtains commodity Chinese medicine preparation.
In the raw medicinal material that the present invention chooses, its effect and pharmacological action are respectively:
Giant knotweed:【Nature and flavor and return through】Slight bitter, is slightly cold.Return liver, courage, lung channel.【Function with cure mainly】Clearing heat and detoxicating, normalizing gallbladder to cure jaundice is dispelled
Wind dampness removing, scattered stasis pain is relieving cough and reducing sputum.For joint pain, jaundice with damp-heat pathogen, Amenorrhea , wei lumps in the abdomen, coughing with a lot of sputum, scald is fallen
Flutter damage, carbuncle sore tumefacting virus.
Sculellaria barbata:Nature and flavor:It is pungent, put down.Indication:Have clearing heat and detoxicating, promoting blood circulation and removing blood stasis, swelling and pain relieving, the effect of anticancer;Control
Appendicitis, hepatitis, stomachache, early liver cancer, lung cancer, cervix cancer, mastitis etc.;The diseases such as the treatment of pain furuncle, treating swelling and pain by traumatic injury are controlled in external application.
Smilax:【Function】Removing toxic substances, dehumidifying, sharp joint.Cure mainly:Syphilis is controlled, stranguria with turbid discharge, muscles and bones contraction pain, tinea pedis treats furunculosis,
Limbs contraction caused by carbuncle swells, scrofula, syphilis and mercury poisoning, arthralgia and myalgia.
The radix paeoniae rubrathe:Function, the row stasis of blood, analgesic, cool blood, detumescence.Cure mainly:Control the stagnant Amenorrhea of the stasis of blood, the accumulation of hernia lump in the abdomen, stomachache, hypochondriac pain, nosebleed
Blood, bloody flux, discharging fresh blood stool, hot eyes, carbuncle swells, injury from falling down.
Turmeric:【Indication】Blood-breaking, it is inducing meastruation to relieve menalgia.Twinged for chest side of body, amenorrhoea, abdominal mass, rheumatism shoulder arm pain,
Tumbling and swelling.Containing curcumin(Curcumin)With in volatile oil volatile oil contain turmerone(Turmerone), zingerene
(Zingerene), phellandrene(Phellandrene), 1,8- Cineoles(1, 8-Cineole), sabinene(Sabinene)、
Borneol(Borneol), dehydroturmerone is still containing arabinose, fructose, glucose, fat oil, starch, oxalates etc..
Field pennycress:Chemical composition:Containing villoside(villoside), morroniside(morroniside), kind wood
Soft-shelled turtle glucoside(loganin)Deng.Nature and flavor:It is cool in nature, taste is pungent, hardship.Indication:It is clearing heat and detoxicating, removing blood stasis and expelling pus.For appendicitis, dysentery
Disease, enteritis, hepatitis, eye conjunctivitis, postpartum blood stasis stomachache, carbuncle swells furunculosis.
Dandelion:【Nature,taste and action】:Sweet, slight bitter is trembled with fear.It is clearing heat and detoxicating, dispersing swelling and dissipating binds.【Cure mainly】:The infection of the upper respiratory tract, eye
Conjunctivitis, mumps, hyperglycaemia, acute mastitis swells and ache, gastritis, dysentery, hepatitis, cholecystitis, acute appendicitis, urinary system sense
Dye, pelvic infecton, carbuncle furuncle furunculosis, pharyngitis controls acute mastitis, adenolymphitis, scrofula, malignant boil carbuncle toxin, acute conjunctivitis, flu hair
Heat, acute tonsillitis, acute bronchitis, urinary tract infections.Containing taraxasterol(Taraxasterol), choline
(Choline), synanthrin(Inulin), pectin(Pectin);Taraxol(Taraxol), stigmasterol(Stigmasterol)、β-
Amyrin(β-Amyrin), cupreol(β-Sitosterol), taraxerol(taraxerol), taraxacin
(Taraxacerin), taraxacin(Taraxacin)With vitamin A, B, C etc..
Radix bupleuri:Clearind deficient heat Chinese medicine, for cold, fever, fevers and chills alternate, malaria, stagnation of QI due to depression of the liver, sternal rib pain, prolapse of the anus, son
Palace comes off, irregular menstruation.Meridian distribution of property and flavor:Cold nature, bitter, pungent, return liver warp, lung channel, the spleen channel.Function:Saturating table expels the heat-evil, soothing the liver solution
It is strongly fragrant, rise and lift yang-energy.Cure mainly:Cold, fever, fevers and chills alternate, malaria, stagnation of QI due to depression of the liver, sternal rib pain, prolapse of the anus, uterus come off, menstruation
It is uncomfortable.
Oldenlandia diffusa:Chemical composition:Herb contains asperuloside, and acetic acid is removed in asperuloside acid, and base asperuloside is sour, all
The acid of square rafter glucoside, Chinese Fevervine Herb time glucoside, Chinese Fevervine Herb time glucoside methyl esters, the p- hydroxyl cinnamyl Chinese Fevervine Herbs of 6-O- time glucoside methyl esters, the p- first of 6-O-
Epoxide cinnamyl Chinese Fevervine Herb time glucoside methyl esters, 6-O- asafoetide acyls Chinese Fevervine Herb time glucoside methyl esters, 2- methyl -3- hydroxy-anthraquiones, 2- methyl -3-
Methoxy anthraquinone, 2- methyl -3- hydroxyl -4- methoxy anthraquinones etc., and ursolic acid, cupreol, hentriacontane, stigmasterol,
Oleanolic acid, cupreol-β-glycoside, p-coumaric acid etc..Cure mainly:Dyspnea and cough due to lung-heat;Abscess of throat;Acute appendicitis;Furuncle sore
Ulcer;Venomous snake bite;Puckery pain of heat gonorrhea;Oedema;Dysentery;Enteritis;Jaundice with damp-heat pathogen;It is good at the various cancerous swellings for the treatment of.Nature and flavor:Bitter, light, property
It is cold.
Stringy stonecrop:Effect of clearing heat and detoxicating, swelling diuretic, apocenosis myogenic etc..【Chemical composition】The different granatum of methyl containing N-
Alkali(N-methylisopelletierine)Dihydro-N-methyl isopelletierine, sedoheptulose(sedoheptulose), Portugal
Grape sugar, fructose, sucrose.【Indication】Eliminating dampness and heat, removing toxic substances.For jaundice with damp-heat pathogen, difficult urination, carbuncle swells sore is acute and chronic
Hepatitis.There is reduction glutamic-pyruvic transaminase to act on.For oxyhepatitis, metastatic hepatitis, chronic hepatitis activity.
The fruit of Chinese wolfberry:【Nature and flavor】It is sweet, put down.【Return through】Return liver and kidney channel.【Indication】It is nourishing liver and kidney, benefiting shrewd head.For void
Labor essence is lost, soreness of waist and knee joint, dizziness and tinnitus, Heat Diabetes, blood deficiency chlorosis, blurred vision.
Radix pseudostellariae:【Meridian distribution of property and flavor】It is sweet, slight bitter, tepor.Enter lung, the spleen channel.【Effect】Help spleen and lung, nourishing generate fluid.
Cough due to deficiency of the lung is controlled, spleen eating less, palpitaition, palpitation, oedema is quenched one's thirst, metal fatigue.
Rhizome of cyrtomium:Function:Return liver, stomach.It is clearing heat and detoxicating, hemostasis, desinsection.For anemopyretic cold, encephalitis B, mumps, blood
Dysentery, hematochezia, metrorrhagia, under band, postpartum vim and vigour distending pain, ascarifuge and pinworm, pathopyretic ulcer.Nature and flavor:It is bitter, puckery, it is slightly cold;【Return
Through】Enter liver, stomach.
Asian puccoon:Nature and flavor:Hardship, trembles with fear.Return through:Enter percardium, Liver Channel.Indication:Cool blood, promoting blood circulation, heat-clearing, removing toxic substances.Control temperature
Hot spot rash, jaundice with damp-heat pathogen, purpura tells, is defeated in battle, hematuria, stranguria with turbid discharge, constipation with heat retention, burn, eczema, erysipelas, large carbuncle.
Radix Glycyrrhizae:It is mild-natured, it is sweet.Indication:Invigorate the spleen and benefit qi, clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain, coordinating the drug actions of a prescription.
For weakness of the spleen and the stomach, lassitude hypodynamia, palpitation, coughing with a lot of sputum, gastral cavity abdomen, four limbs contraction, carbuncle sore tumefacting virus alleviate medicine poison
It is property, strong.Chemical composition:Radix Glycyrrhizae contains various chemical compositions, and main component has glycyrrhizic acid, liquiritin etc..Separated from Radix Glycyrrhizae
The compound for going out has glycyrrhizin, enoxolone, liquiritin, isoliquiritin, neoliquriitin, neoisoliquiritin, glycyrrhizin, different sweet
The tens of kinds of compounds such as careless element and licoricidin, glycyrol, isoglycyrol, 7- methylcoumarins essence, umbelliferone.
Morinda officinalis:Cure mainly impotence and seminal emission, uterus cold infertile, irregular menstruation, few abdomen crymodynia, arthralgia pain due to rheumatism, muscles and bones impotence.
Prepared rhizome of rehmannia:Sweet slightly warm in nature, returns liver and kidney channel, there is nourishing the blood and yin, effect of enriching essence and nourishing marrow, it is adaptable to syndrome of blood deficiency, woman
Female's irregular menstruation, syndrome of yin deficiency of liver and kidney, diabete, blood and essence asthenia card etc..Cultivated land is nourishing liver and kidney important drugs, can not only be supported
Blood enriching yin, and can production of sperm fill out marrow.Prepared rhizome of rehmannia has anti-lipid peroxidation, improves the effect such as activities of antioxidant enzymes, and energy
Lowering blood pressure and blood fat, inhibition thrombosis, improvement myocardial ischemia etc..
Rattletop:Rising Yang, delivers, promoting eruption, removing toxic substances.【Indication】When gas plague, fever and chills of having a headache, prickly heat heat itches, and has sore throat, and dashes forward
Swell poison, stomach energy toothache, dispute sore, macula is impermeable;The sinking of qi of middle-jiao, protracted dysentery and diarrhea, prolapse of the anus, women is collapsed, band, uterus tenesmus;Carbuncle
Swollen sore gas is micro-, mildly bitter flavor and it is puckery.
Ramulus Taxilli:【Chemical composition】Branch, leaf are wormwood artemisia Avicularin containing avicularin(avicularin), and containing Quercetin
(quercetin)Deng.【Indication】Filling liver kidney;Strengthening the bones and muscles;Wind-damp dispelling;It is antiabortive.Main soreness of waist and knee joint;Muscles and bones impotence is weak;Limbs are inclined
It is withered;Arthralgia pain due to rheumatism;Head is wrong dizzy;Fetal irritability, metrostaxis.For arthralgia pain due to rheumatism, soreness and weakness of waist and knees, muscles and bones is powerless, uterine bleeding warp
It is many, blood leaking in gestation, fetal irritability;Hypertension.
Imitated with the raw medicinal material property of medicine selected by top it is complementary, evaded the mutual inhibition of compatibility between medicine, mutual restraint between two drugs, the mutual-detoxication it
Choosing, makes medicine mutual reinforcement between, mutually makes effect significantly, with enhance immunity effect.Qinghua ecchymosis, nourishing liver can be reached in treatment
Kidney, the purpose for replenishing qi to invigorate the spleen.It is for oral administration that there is definite curative effect to chronic hepatitis B.Effect of Chinese medicine preparation of the present invention should in clinic
Confirmed with central, clinical test of pesticide effectiveness material and model case:
1. Cai XX, male, 52 years old.On March 21st, 2000 goes to a doctor:Main suit's pain in the right hypochondrium, receives difference, weak more than 2 years, in November, 1998, because
Pain in the right hypochondrium, receives difference, weak, checks blood liver function, and hepatitis B immune index, HBcAb is positive all the time.Through with inosine,
Manyzoned polypore gantai etc. is treated 10 months, and HBcAb is positive all the time.Quarter examines:Receive difference, spiritlessness and weakness, when have right flank secret anguish
Or it is uncomfortable, dry, raw meat is swollen, and fart is more, stool day row 2 times, loose stool, yellow urine.Check:Refreshing clear, dark complexion is black dull.Diagnosis:Slowly
Sexuality type hepatitis B.Control with Qinghua ecchymosis, nourishing liver and kidney, replenish qi to invigorate the spleen method.Clothes we 30 doses after, occasionally have dull pain in liver or
Discomfort, mouthfeel mitigates, not endurance, and still, stool day row 1 time shapes, complexion dark dim reddish appetite, and color is yellow.Red tongue body
Hidden purple, yellow,greasy and thin fur, arteries and veins is fine and smooth.After continuing to take 50 doses of we, occasionally there is uncomfortable liver area, not endurance, complexion is dark dim substantially good
Turn, basic multiple normal, still, two is just normal, and the hidden purple of red tongue body, the thin Huang of tongue, arteries and veins is thin for appetite.60 doses of we are taken again, and symptom disappears,
Recover.
Method and effective dose:20 parts of giant knotweed, 20 parts of Sculellaria barbata, 25 parts of smilax, 15 parts of the radix paeoniae rubrathe, 15 parts of turmeric, field pennycress
20 parts, 20 parts of dandelion, 10 parts of radix bupleuri, 25 parts of oldenlandia diffusa, 25 parts of stringy stonecrop, 15 parts of the fruit of Chinese wolfberry, 18 parts of radix pseudostellariae, rhizome of cyrtomium
15 parts, 15 parts of Asian puccoon, 6 parts of Radix Glycyrrhizae, 15 parts of Morinda officinalis, 20 parts of prepared rhizome of rehmannia, 15 parts of rattletop, 20 parts of Ramulus Taxilli.
It is following steps that its preparation method is:Step one), weigh 20 parts of bulk drug polygonum cuspidatum, 20 parts of Sculellaria barbata, smilax
25 parts, 15 parts of the radix paeoniae rubrathe, 15 parts of turmeric, 20 parts of field pennycress, 20 parts of dandelion, 10 parts of radix bupleuri, 25 parts of oldenlandia diffusa, stringy stonecrop 25
Part, 15 parts of the fruit of Chinese wolfberry, 18 parts of radix pseudostellariae, 15 parts of rhizome of cyrtomium, 15 parts of Asian puccoon, 6 parts of Radix Glycyrrhizae, 15 parts of Morinda officinalis, 20 parts of prepared rhizome of rehmannia, rattletop
15 parts, 20 parts of Ramulus Taxilli, go the removal of impurity, are eluriated rapidly with cold boiled water water, drain aqueous, dry;
Step 2), step one)Obtained raw medicinal material is respectively prepared medicine materical crude slice, puts in suitable decocting device, adds clear water appropriate, leaching
Bubble suitable time, is heated to boiling, keeps slight boiling condition certain hour(About 1.5 ~ 2 hours), separate fried liquid;
Step 3), step 2)The dregs of a decoction after being filtered add water appropriate decoction, after decocting 2 ~ 3 times by regulation, merge
Fried liquid, filtering or the fried liquid of sedimentation separation;
Step 4), step 3)Obtained Chinese medicine preparation is packed, and obtains commodity Chinese medicine preparation.
Based on decoction oral, daily 1 dose, it is decocted in water for oral dose, respectively takes 1 time sooner or later, each 130ml warmly takes.
Specific embodiment
The detoxicating stagnation resolvation tonifying liver soup, the raw medicinal material of use is respectively:20 parts of giant knotweed, 20 parts of Sculellaria barbata, smilax 25
Part, 15 parts of the radix paeoniae rubrathe, 15 parts of turmeric, 20 parts of field pennycress, 20 parts of dandelion, 10 parts of radix bupleuri, 25 parts of oldenlandia diffusa, stringy stonecrop 25
Part, 15 parts of the fruit of Chinese wolfberry, 18 parts of radix pseudostellariae, 15 parts of rhizome of cyrtomium, 15 parts of Asian puccoon, 6 parts of Radix Glycyrrhizae, 15 parts of Morinda officinalis, 20 parts of prepared rhizome of rehmannia, rattletop
15 parts, 20 parts of Ramulus Taxilli.
It is following steps that its preparation method is:Step one), weigh 20 parts of bulk drug polygonum cuspidatum, 20 parts of Sculellaria barbata, smilax
25 parts, 15 parts of the radix paeoniae rubrathe, 15 parts of turmeric, 20 parts of field pennycress, 20 parts of dandelion, 10 parts of radix bupleuri, 25 parts of oldenlandia diffusa, stringy stonecrop 25
Part, 15 parts of the fruit of Chinese wolfberry, 18 parts of radix pseudostellariae, 15 parts of rhizome of cyrtomium, 15 parts of Asian puccoon, 6 parts of Radix Glycyrrhizae, 15 parts of Morinda officinalis, 20 parts of prepared rhizome of rehmannia, rattletop
15 parts, 20 parts of Ramulus Taxilli, go the removal of impurity, are eluriated rapidly with cold boiled water water, drain aqueous, dry;
Step 2), step one)Obtained raw medicinal material is respectively prepared medicine materical crude slice, puts in suitable decocting device, adds clear water appropriate, leaching
Bubble suitable time, is heated to boiling, keeps slight boiling condition certain hour(About 1.5 ~ 2 hours), separate fried liquid;
Step 3), step 2)The dregs of a decoction after being filtered add water appropriate decoction, after decocting 2 ~ 3 times by regulation, merge
Fried liquid, filtering or the fried liquid of sedimentation separation;
Step 4), step 3)Obtained Chinese medicine preparation is packed, and obtains commodity Chinese medicine preparation.
Claims (2)
1. a kind of detoxicating stagnation resolvation tonifying liver soup, it is characterised in that the raw medicinal material of use is respectively:20 parts of giant knotweed, Sculellaria barbata
20 parts, 25 parts of smilax, 15 parts of the radix paeoniae rubrathe, 15 parts of turmeric, 20 parts of field pennycress, 20 parts of dandelion, 10 parts of radix bupleuri, oldenlandia diffusa 25
Part, 25 parts of stringy stonecrop, 15 parts of the fruit of Chinese wolfberry, 18 parts of radix pseudostellariae, 15 parts of rhizome of cyrtomium, 15 parts of Asian puccoon, 6 parts of Radix Glycyrrhizae, 15 parts of Morinda officinalis, cultivated land
Yellow 20 parts, 15 parts of rattletop, 20 parts of Ramulus Taxilli.
2. it is according to claim 1 detoxicating stagnation resolvation tonifying liver soup, it is characterised in that:Its preparation method, preparation method be for
Lower step:Step one), weigh 20 parts of bulk drug polygonum cuspidatum, 20 parts of Sculellaria barbata, 25 parts of smilax, 15 parts of the radix paeoniae rubrathe, 15 parts of turmeric,
20 parts of field pennycress, 20 parts of dandelion, 10 parts of radix bupleuri, 25 parts of oldenlandia diffusa, 25 parts of stringy stonecrop, 15 parts of the fruit of Chinese wolfberry, radix pseudostellariae 18
Part, 15 parts of rhizome of cyrtomium, 15 parts of Asian puccoon, 6 parts of Radix Glycyrrhizae, 15 parts of Morinda officinalis, 20 parts of prepared rhizome of rehmannia, 15 parts of rattletop, 20 parts of Ramulus Taxilli, go removal of impurities
Matter, is eluriated rapidly with cold boiled water water, drains aqueous, is dried;
Step 2), step one)Obtained raw medicinal material is respectively prepared medicine materical crude slice, puts in suitable decocting device, adds clear water appropriate, leaching
Bubble suitable time, is heated to boiling, keeps slight boiling condition certain hour(About 1.5 ~ 2 hours), separate fried liquid;
Step 3), step 2)The dregs of a decoction after being filtered add water appropriate decoction, after decocting 2 ~ 3 times by regulation, merge
Fried liquid, filtering or the fried liquid of sedimentation separation;
Step 4), step 3)Obtained Chinese medicine preparation is packed, and obtains commodity Chinese medicine preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710049691.8A CN106729436A (en) | 2017-01-23 | 2017-01-23 | Detoxicating stagnation resolvation tonifying liver soup |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710049691.8A CN106729436A (en) | 2017-01-23 | 2017-01-23 | Detoxicating stagnation resolvation tonifying liver soup |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106729436A true CN106729436A (en) | 2017-05-31 |
Family
ID=58943234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710049691.8A Pending CN106729436A (en) | 2017-01-23 | 2017-01-23 | Detoxicating stagnation resolvation tonifying liver soup |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106729436A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114832081A (en) * | 2022-05-30 | 2022-08-02 | 时圣运 | A Chinese medicinal composition for treating and preventing liver diseases |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104474360A (en) * | 2014-11-03 | 2015-04-01 | 景东旭 | Traditional Chinese medicine preparation for treating liver abscess |
CN106215127A (en) * | 2016-09-07 | 2016-12-14 | 四川金堂海纳生物医药技术研究所 | A kind of for decoction medicine treating chronic hepatitis B and preparation method thereof |
-
2017
- 2017-01-23 CN CN201710049691.8A patent/CN106729436A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104474360A (en) * | 2014-11-03 | 2015-04-01 | 景东旭 | Traditional Chinese medicine preparation for treating liver abscess |
CN106215127A (en) * | 2016-09-07 | 2016-12-14 | 四川金堂海纳生物医药技术研究所 | A kind of for decoction medicine treating chronic hepatitis B and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
张兆旺: "《中药药剂学》", 31 March 2007, 中国中医药出版社 * |
隋殿军主编: "《国家级名医秘验方》", 31 May 2008, 吉林科学技术出版 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114832081A (en) * | 2022-05-30 | 2022-08-02 | 时圣运 | A Chinese medicinal composition for treating and preventing liver diseases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101912585B (en) | Medicament for treating myoma of uterus and preparation method thereof | |
CN106267120A (en) | A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof | |
CN103920034B (en) | Chinese medicine composition and the method for making of the side reaction of ameliorate tumor chemotherapy of patients | |
CN104435168A (en) | Drug for treating pressure sores | |
CN104435326A (en) | Traditional Chinese medicine preparation for treating acute mastitis | |
CN105497780A (en) | Decoction for harmonizing stomach, protecting mucosa and relieving pain | |
CN106729436A (en) | Detoxicating stagnation resolvation tonifying liver soup | |
CN103751721A (en) | Traditional Chinese medicinal composition for treating bladder cancer | |
CN104042974A (en) | Traditional Chinese medicament for treating diabetes mellitus | |
CN103656525A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
CN106266973A (en) | Stomach function regulating cuticula pain relieving soup | |
CN105435131A (en) | Traditional Chinese medicine composition for treating chronic heart failure and preparation method thereof | |
CN104606661A (en) | Traditional Chinese medicinal galactagogue for treating hypogalactia after cesarean delivery and preparation method of galactagogue | |
CN106361881A (en) | Decoction medicament for treating scrotal eczema and preparation method of decoction medicament | |
CN101112436A (en) | Chinese medicine preparation for treating bacchia | |
CN105267940A (en) | Traditional Chinese medicine composition for preventing and treating gastric ulcer and preparation method thereof | |
CN104383361A (en) | Traditional Chinese medicine preparation for treating acute infectious hepatitis | |
CN105381410A (en) | Traditional Chinese medicinal preparation for treating hepatitis | |
CN105456954A (en) | Traditional Chinese medicine composition for treating acne and preparation thereof | |
CN105456933A (en) | Traditional Chinese medicine capable of activating blood to remove stasis and clearing and activating channels and collaterals and preparation method of traditional Chinese medicine | |
CN105213543A (en) | A kind of Chinese medicine oral liquid and preparation method for the treatment of polycystic ovary syndrome | |
CN105056043A (en) | Traditional Chinese medicine for treating salpingitis | |
CN105031562A (en) | Blood activating and dryness moistening wine | |
CN104225094A (en) | Traditional Chinese medicine preparation for treating Behcet's syndrome | |
CN104352891A (en) | Traditional Chinese medicine preparation for treating angina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170531 |